acetylcysteine has been researched along with Dry Eye in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Cao, X; Chen, P; Di, G; Wang, D; Wang, Y; Zhang, K; Zhao, H | 1 |
| Hoeller, S; Knoetzl, W; Nepp, J; Prinz, A; Prinz, M | 1 |
| Choi, KR; Han, KE; Jun, RM; Lee, SM | 1 |
| Crist, AJ | 1 |
| Baumgartner, R; Garhöfer, G; Höller, S; Kaya, S; O'Rourke, M; Peterson, W; Prinz, M; Schmetterer, L; Schmidl, D; Unterhuber, A; Werkmeister, R; Witkowska, KJ; Wolter, A | 1 |
| Dua, HS; Messina, M | 1 |
| Eom, Y; Kang, B; Kim, HM; Lee, HK; Li, X; Song, JS; Woo, IH | 1 |
| Chen, W; Hua, S; Qu, J; Reinach, PS; Ren, Y; She, Y; Xiao, B; Zheng, Q | 1 |
| Chen, W; Lu, H; Qu, J; Reinach, PS; Ren, Y; Xiao, B; Zheng, Q; Zhu, Y | 1 |
| Chae, JJ; Chuck, RS; Hongyok, T; Li, L; Na, D; Shin, YJ | 1 |
| Baggiani, A; Carelli, V; Di Colo, G; Serafini, MF; Zambito, Y | 1 |
| Bradić, M; Petricek, G; Petricek, I; Pokupec, R; Popović-Suić, S; Sikić, J | 1 |
1 trial(s) available for acetylcysteine and Dry Eye
| Article | Year |
|---|---|
A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
Topics: Acetylcysteine; Adult; Chitosan; Cohort Studies; Double-Blind Method; Dry Eye Syndromes; Female; Humans; Male; Tears; Tomography, Optical Coherence | 2017 |
11 other study(ies) available for acetylcysteine and Dry Eye
| Article | Year |
|---|---|
Aquaporin5 Deficiency Aggravates ROS/NLRP3 Inflammasome-Mediated Pyroptosis in the Lacrimal Glands.
Topics: Acetylcysteine; Animals; Caspase 1; Cell Line; Dry Eye Syndromes; Inflammasomes; Lacrimal Apparatus; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Reactive Oxygen Species | 2023 |
Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series.
Topics: Acetylcysteine; Adult; Aged; Chitosan; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Tears; Treatment Outcome; Young Adult | 2020 |
Clinical Manifestation and Risk Factors Associated With Remission in Patients With Filamentary Keratitis.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Brain Diseases; Child; Dry Eye Syndromes; Eye Injuries; Female; Fluorescein; Follow-Up Studies; Free Radical Scavengers; Humans; Keratitis; Male; Middle Aged; Ophthalmologic Surgical Procedures; Remission Induction; Retrospective Studies; Risk Factors; Serum; Slit Lamp Microscopy | 2020 |
Case Report: Management of Refractory Filamentary Keratitis with N-acetylcysteine.
Topics: Acetylcysteine; Aged; Cornea; Dry Eye Syndromes; Humans; Keratitis; Male; Tears | 2021 |
Early results on the use of chitosan-N-acetylcysteine (Lacrimera
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chitosan; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Keratitis; Lubricant Eye Drops; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Time Factors; Treatment Outcome | 2019 |
Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.
Topics: Acetylcysteine; Administration, Ophthalmic; Animals; Cell Count; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Expectorants; Goblet Cells; Male; Microscopy, Electron, Scanning; Mucin 5AC; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tears | 2018 |
Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye.
Topics: Acetylcysteine; Analysis of Variance; Animals; Carrier Proteins; Caspase 1; Conjunctiva; Cornea; Disease Models, Animal; Disease Progression; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Female; Free Radical Scavengers; Inflammasomes; Interleukin-1beta; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Signal Transduction | 2014 |
Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients.
Topics: Acetylcysteine; Adult; Blotting, Western; Carrier Proteins; Caspase 1; Cell Line; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Epithelium, Corneal; Female; Gene Knockdown Techniques; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Keratitis; Male; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Osmotic Pressure; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Transfection; Young Adult | 2015 |
Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Topics: Acetylcysteine; Administration, Topical; Animals; Blinking; Botulinum Toxins; Botulinum Toxins, Type A; Chitosan; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescent Antibody Technique, Indirect; Fluorometholone; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tears | 2009 |
Methyl-DEAE-dextran: a candidate biomaterial.
Topics: Acetylcysteine; Biocompatible Materials; DEAE-Dextran; Drug Delivery Systems; Dry Eye Syndromes; Humans; Hydrogels; Hydrogen-Ion Concentration; Materials Testing; Methylation; Ophthalmic Solutions | 2004 |
[Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome].
Topics: Acetylcysteine; Adult; Aged; Dry Eye Syndromes; Expectorants; Female; Humans; Male; Middle Aged; Ophthalmic Solutions | 2005 |